Launch week offerEnds in00h00m00s

annual Promonthly Pro

Joan Forns

Health Solutions

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (8)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2021

Year:

2020

Collaborators (17)

Lia Gutierrez

Health Solutions

UNITED STATES

View details

Rebecca MacKay

Health Solutions

UNITED STATES

View details

Estel Plana

Health Solutions

UNITED STATES

View details

J. Bradley Layton

Health Solutions

UNITED STATES

View details

Andrea Margulis

Health Solutions

UNITED STATES

View details

Xabier Garcia-Albeniz

Health Solutions

UNITED STATES

View details

MARIA ELENA RIVERO FERRER

Health Solutions

UNITED STATES

View details

Lisa McQuay

Health Solutions

UNITED STATES

View details

Nuria Riera-Guardia

Health Solutions

UNITED STATES

View details

Maria Giner-Soriano

Collaborator teacher (Professora col·laboradora)

Universitat de Girona

SPAIN

View details

Alejandro ARANA

Health Solutions

UNITED STATES

View details

Cristina Rebordosa

Health Solutions

UNITED STATES

View details

Samantha Martin

Head of Research

Drug Safety Research Unit

UNITED KINGDOM

View details

Jonas Reinold

Leibniz Institute for Prevention Research and Epidemiology - BIPS

GERMANY

View details

David Martínez

Health Solutions

UNITED STATES

View details

Mary Anthony

Health Solutions

UNITED STATES

View details

Heather Danysh

Health Solutions

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joan Forns

Research Interests

Make your next move.

Explore related searches

Articles (8)

Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222

Plain language summary of mortality rates of patients with Parkinson’s disease psychosis who were treated either with pimavanserin or with different second-generation (atypical) antipsychotics

Evaluation of Mortality in Users of Pimavanserin Compared with Other Atypical Antipsychotics in Patients with Parkinson’s Disease Psychosis: An Update

Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databases

The challenges for pharmacoepidemiologists identifying migraine in electronic healthcare data sources

Effect of Different Durations of Treatment With Antihypertensive Drugs With Anticholinergic Effects on the Risk of Dementia: A Target Trial Emulation Study

Increased risk of falls and fractures in patients with psychosis and Parkinson disease.

Early Life Exposure to Perfluoroalkyl Substances (PFAS) and ADHD: A Meta-Analysis of Nine European Population-Based Studies.

Collaborators (17)

Lia Gutierrez

Rebecca MacKay

Estel Plana

J. Bradley Layton

Andrea Margulis

Xabier Garcia-Albeniz

MARIA ELENA RIVERO FERRER

Lisa McQuay

Nuria Riera-Guardia

Maria Giner-Soriano

Alejandro ARANA

Cristina Rebordosa

Samantha Martin

Jonas Reinold

David Martínez

Mary Anthony

Heather Danysh

Make your next move.